| 161 |
Levothyroxine
|
-
Levothyroxine, CAS-RN: 51-48-9, DTXSID8023214
|
None
|
| 694 |
Liarozole
|
-
Liarozole, CAS-RN: 115575-11-6, DTXSID9048277
|
None
|
| 483 |
LiCl
|
|
None
|
| 99 |
Lidocaine
|
-
Lidocaine, CAS-RN: 137-58-6, DTXSID1045166
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 415 |
Light (290-700 nm)
|
|
282: Adverse outcome pathway on photochemical toxicity initiated by light exposure
|
| 112 |
Lindane
|
-
Lindane, CAS-RN: 58-89-9, DTXSID2020686
|
10: Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain
|
| 564 |
Linuron
|
-
Linuron, CAS-RN: 330-55-2, DTXSID2024163
|
None
|
| 376 |
Lipopolysaccharride
|
-
Lipopolysaccharride, CAS-RN: NOCAS, DTXSID4036695
|
237: Substance interaction with lung resident cell membrane components leading to atherosclerosis
|
| 551 |
Losartan
|
-
Losartan, CAS-RN: 114798-26-4, DTXSID7023227
|
319: Binding to ACE2 leading to lung fibrosis
|
| 779 |
lotenone
|
|
475: Binding of chemicals to ionotropic glutamate receptors leads to impairment of learning and memory via loss of drebrin from dendritic spines of neurons
|
| 502 |
Low LET Radiation
|
|
None
|
| 334 |
low molecular weight proteins
|
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 374 |
LPS
|
|
None
|
| 575 |
Lysodren, Mitotan, Mitotane
|
-
Lysodren, Mitotan, Mitotane, CAS-RN: 164203-73-0, DTXSID30425146
|
349: Inhibition of 11β-hydroxylase leading to decresed population trajectory
|
| 245 |
Makisterone A
|
|
4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
|
| 546 |
Malathion
|
-
Malathion, CAS-RN: 121-75-5, DTXSID4020791
|
2 AOPs
|
| 606 |
Malonoben
|
-
Malonoben, CAS-RN: 10537-47-0, DTXSID1042106
|
None
|
| 314 |
Mancozeb
|
-
Mancozeb, CAS-RN: 8018-01-7, DTXSID0034695
|
242: Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity
|
| 33 |
Maneb
|
-
Maneb, CAS-RN: 12427-38-2, DTXSID9020794
|
242: Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity
|
| 721 |
Manganese
|
-
Manganese, CAS-RN: 7439-96-5, DTXSID2024169
|
2 AOPs
|
| 263 |
Meclofenamic acid
|
-
Meclofenamic acid, CAS-RN: 644-62-2, DTXSID0048559
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 679 |
Meconium
|
|
None
|
| 189 |
Mefenamic acid
|
-
Mefenamic acid, CAS-RN: 61-68-7, DTXSID5023243
|
None
|
| 192 |
Meloxicam
|
-
Meloxicam, CAS-RN: 71125-38-7, DTXSID1020803
|
177: Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
|
| 271 |
Mental stress
|
|
403: combined unhealthy lifestyle factors leading to metabolic syndrome
|